These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 37695433)
1. Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Lattanzi S; Trinka E; Russo E; Del Giovane C; Matricardi S; Meletti S; Striano P; Damavandi PT; Silvestrini M; Brigo F Drugs; 2023 Oct; 83(15):1409-1424. PubMed ID: 37695433 [TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first-line add-on therapies for seizures in Dravet syndrome: A network meta-analysis. Guerrini R; Chiron C; Vandame D; Linley W; Toward T Epilepsia Open; 2024 Apr; 9(2):689-703. PubMed ID: 38427284 [TBL] [Abstract][Full Text] [Related]
3. Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: An indirect treatment comparison. Devi N; Madaan P; Asrar MM; Sahu JK; Bansal D Seizure; 2021 Oct; 91():316-324. PubMed ID: 34274891 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of adjunctive antiseizure medications for dravet syndrome: A systematic review and network meta-analysis. Wu J; Zhang L; Zhou X; Wang J; Zheng X; Hu H; Wu D Front Pharmacol; 2022; 13():980937. PubMed ID: 36120377 [No Abstract] [Full Text] [Related]
5. Anti-seizure medications for Lennox-Gastaut syndrome. Brigo F; Jones K; Eltze C; Matricardi S Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230 [TBL] [Abstract][Full Text] [Related]
6. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis. Lattanzi S; Trinka E; Zaccara G; Striano P; Russo E; Del Giovane C; Silvestrini M; Brigo F Drugs; 2022 Feb; 82(2):199-218. PubMed ID: 35061214 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of pharmacological treatments for Dravet syndrome: Systematic review and network meta-analysis. Xia D; Zhang P; Chen Y; Liu X; Chen Y Seizure; 2024 Apr; 117():90-97. PubMed ID: 38354598 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of fenfluramine in patients with Dravet syndrome: A meta-analysis. Zhang L; Li W; Wang C Acta Neurol Scand; 2021 Apr; 143(4):339-348. PubMed ID: 33336426 [TBL] [Abstract][Full Text] [Related]
10. The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis. Gil-Nagel A; Falip M; Sánchez-Carpintero R; Abad-Sazatornil MR; Poveda JL; Aibar JÁ; Cardenal-Muñoz E; Aras LM; Sánchez R; Sancho-López A; Trillo-Mata JL; Torrejón M; Gil A Epilepsy Behav; 2022 Jul; 132():108711. PubMed ID: 35588562 [TBL] [Abstract][Full Text] [Related]
11. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial. Lagae L; Sullivan J; Knupp K; Laux L; Polster T; Nikanorova M; Devinsky O; Cross JH; Guerrini R; Talwar D; Miller I; Farfel G; Galer BS; Gammaitoni A; Mistry A; Morrison G; Lock M; Agarwal A; Lai WW; Ceulemans B; Lancet; 2019 Dec; 394(10216):2243-2254. PubMed ID: 31862249 [TBL] [Abstract][Full Text] [Related]
12. Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial. Miller I; Scheffer IE; Gunning B; Sanchez-Carpintero R; Gil-Nagel A; Perry MS; Saneto RP; Checketts D; Dunayevich E; Knappertz V; JAMA Neurol; 2020 May; 77(5):613-621. PubMed ID: 32119035 [TBL] [Abstract][Full Text] [Related]
13. Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome. Bishop KI; Isquith PK; Gioia GA; Gammaitoni AR; Farfel G; Galer BS; Nabbout R; Wirrell EC; Polster T; Sullivan J Epilepsy Behav; 2021 Aug; 121(Pt A):108024. PubMed ID: 34023810 [TBL] [Abstract][Full Text] [Related]
15. Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy. Brigo F; Igwe SC; Bragazzi NL Cochrane Database Syst Rev; 2017 May; 5(5):CD010483. PubMed ID: 28521067 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis. Tong J; Ji T; Liu T; Liu J; Chen Y; Li Z; Lu N; Li Q Epilepsy Behav; 2024 Mar; 152():109653. PubMed ID: 38277848 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of fenfluramine in patients with Dravet syndrome: A systematic review and meta-analysis. Sharawat IK; Panda PK; Kasinathan A; Panda P; Dawman L; Joshi K Seizure; 2021 Feb; 85():119-126. PubMed ID: 33461030 [TBL] [Abstract][Full Text] [Related]
18. A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome. Schoonjans AS; Ceulemans B Expert Rev Neurother; 2022 May; 22(5):351-364. PubMed ID: 33455486 [TBL] [Abstract][Full Text] [Related]
19. A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication. Strzelczyk A; Schubert-Bast S CNS Drugs; 2022 Mar; 36(3):217-237. PubMed ID: 35156171 [TBL] [Abstract][Full Text] [Related]
20. Stiripentol for the treatment of seizures associated with Dravet syndrome. Chiron C Expert Rev Neurother; 2019 Apr; 19(4):301-310. PubMed ID: 30900478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]